AGP Executive Report
Last update: 10 hours agoPsoriatic Arthritis Drug Update: Bimekizumab showed sustained improvements over two years in pain, fatigue, physical function and overall disease impact for psoriatic arthritis patients, with swollen-joint resolution linked to the biggest patient-reported relief. Hospital GenAI in France: Rouen University Hospital (CHU de Rouen) has chosen Orange Business’s Live Intelligence to deploy a secure, sovereignty-focused generative AI platform across its public-hospital network, including faster research grant workflows. Rare Disease Pharma: Chiesi Global Rare Diseases says the European Commission approved lomitapide capsules for children aged 5+ with homozygous familial hypercholesterolaemia, expanding an existing adult indication. Climate & Health Funding: France’s dwindling climate funding is under scrutiny after record May heat, with experts warning heatwaves are getting hotter, longer and more frequent. Food Safety & Climate: An EU-funded project (HOLiFOOD) launches a digital campaign for World Food Safety Day to explain how climate change can raise risks like Salmonella, Campylobacter and crop toxins. Mental Health Care Innovation: A French psychiatric hospital is using therapy donkeys to support patients, with reported positive reception.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
